{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:45:50Z","timestamp":1751053550109},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":7421,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1992,4]]},"abstract":"<jats:p>1. The aims of this study were to investigate the partial agonist profile of carteolol and evaluate methodology for differentiating relative beta 1 and beta 2 partial agonist activity (PAA) in vivo. 2. Eight normal subjects received single oral doses of carteolol 10 mg, 30 mg and 60 mg; nadolol 40 mg; pindolol 30 mg and placebo, given in a single\u2010blind, randomised crossover design. 3. beta 1\u2010PAA was demonstrated with carteolol by dose\u2010related increases in resting heart rate and systolic blood pressure, and a plateau in the dose\u2010response curve for attenuation of exercise tachycardia. beta 2\u2010PAA with carteolol was evidenced by a dose\u2010related increase in resting finger tremor and progressive attenuation of exercise\u2010induced hyperkalaemia. beta 2\u2010adrenoceptor antagonism was shown by attenuation of terbutaline induced hypokalaemic, chronotropic and finger tremor responses. 4. Carteolol behaved as a non\u2010selective beta\u2010adrenoceptor antagonist with both beta 1 and beta 2\u2010PAA components. In the standard clinical dose range of 10\u201030 mg, its in vivo PAA effects were relatively beta 1\u2010 selective. Thus at low doses, there appeared to be a dissociation between selectivity of antagonist and partial agonist activity. 5. Attenuation of exercise hyperkalaemia appears to be a novel and sensitive method for the evaluation of beta 2\u2010PAA in vivo.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1992.tb04060.x","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T03:16:46Z","timestamp":1343359006000},"page":"411-416","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of in vivo partial beta 1\/beta 2\u2010agonist activity: a dose\u2010 ranging study with carteolol."],"prefix":"10.1111","volume":"33","author":[{"given":"NM","family":"Wheeldon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DG","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BJ","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02689.x"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.164"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1183\/09031936.93.01030227","article-title":"Evidence for a dual effect by beta\u2010adrenoceptor antagonists on post\u2010exercise airway calibre","volume":"1","author":"Berkin K. E.","year":"1988","journal-title":"Eur. resp. J."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03006.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90880-5"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.53.6.752"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.41.12.1256"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1976.tb00348.x"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.111"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jama.1980.03300300018017","article-title":"Plasma catecholamines in stress and exercise","volume":"243","author":"Dimsdale J. E.","year":"1980","journal-title":"J. Am. med. Ass."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1977.tb04609.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.65.3.546"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.64"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1983.tb10062.x"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00544023"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03510.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558154"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00679788"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03215.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198805000-00006"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977215556"},{"key":"e_1_2_1_23_1","first-page":"19A","article-title":"Cardiopulmonary effects of exercise after oral administration of the beta\u2010blocker carteolol","volume":"28","author":"Pauvlik J. M.","year":"1980","journal-title":"Clin. Res."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb05187.x"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558246"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90545-1"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.211"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.146"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0740397"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00618509"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03760.x"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198503283121304"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1992.tb04060.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1992.tb04060.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T13:44:12Z","timestamp":1698068652000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1992.tb04060.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1992,4]]}},"alternative-id":["10.1111\/j.1365-2125.1992.tb04060.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1992.tb04060.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,4]]}}}